Cardiomems
Payments companies reported to CMS as associated with Cardiomems. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cardiomems, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cardiomems
These are the largest totals companies reported as associated with Cardiomems. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott Lundgren | Omaha, NE | Advanced Heart Failure and Transplant Cardiology | $102,029.04 |
| Patrick Mccann | Columbia, SC | Advanced Heart Failure and Transplant Cardiology | $99,206.96 |
| Kunjan Bhatt | Austin, TX | Advanced Heart Failure and Transplant Cardiology | $86,923.99 |
| Aman Shah | Roslyn, NY | Cardiovascular Disease | $82,233.57 |
| Jerome Thomas | Austin, TX | Advanced Heart Failure and Transplant Cardiology | $76,478.57 |
| Christina Sauld | Milwaukee, WI | Nurse Practitioner | $68,707.32 |
| Terrie-Ann Benjamin | Saint Paul, MN | Advanced Heart Failure and Transplant Cardiology | $67,609.05 |
| Shelley Hall | Dallas, TX | Advanced Heart Failure and Transplant Cardiology | $65,745.76 |
| Francis Zidar | Austin, TX | Interventional Cardiology | $62,772.34 |
| Ezequiel Molina | Atlanta, GA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $48,429.99 |
Prescribed Cardiomems?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.